[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354114-105":59,"doc-detail-354114-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-cancer-associated-fibroblast-derived-exosomes-in-pancreatic-cancer-clinical-therapeutic-potential-and-targeting-challenges","Role of cancer-associated fibroblast-derived exosomes in pancreatic cancer: clinical therapeutic potential and targeting challenges","","Pancreatic cancer lethality is driven by late diagnosis and persistent treatment resistance. The tumor microenvironment, shaped by cancer-associated fibroblasts (CAFs), supports malignant progression through exosomes released by multiple cell types. CAF-derived exosomes (CAF-EXOs) deliver proteins, lipids, and non-coding RNAs that enhance proliferation, invasion, metastasis, metabolic reprogramming, and chemoresistance. By connecting CAF-EXOs with liquid-biopsy biomarkers and therapeutic targeting, the review examines translational strategies and the major biological and technological barriers to clinical implementation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-cancer-associated-fibroblast-derived-exosomes-in-pancreatic-cancer-clinical-therapeutic-potential-and-targeting-challenges/354114/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-cancer-associated-fibroblast-derived-exosomes-in-pancreatic-cancer-clinical-therapeutic-potential-and-targeting-challenges/354114.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does pancreatic cancer often have poor outcomes?","Question",{"text":112,"@type":113},"Most patients are diagnosed at advanced stages due to limited early symptoms, and treatment resistance leads to low long-term survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do CAF-derived exosomes play in pancreatic cancer?",{"text":117,"@type":113},"CAF-derived exosomes transmit molecular cargo that promotes tumor proliferation, invasion, metastasis, metabolic reprogramming, and chemoresistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How could CAF-EXOs be used clinically?",{"text":121,"@type":113},"They can serve as liquid biopsy biomarkers for early detection and as therapeutic targets to disrupt stromal-driven resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354114,1790172682,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","TYPE Review  \nPUBLISHED 22 April 2026  \nDOI 10.3389/fimmu.2026.1805988  \nOPEN ACCESS  \nEDITED BY  \nEyad Elkord,  \nXi’an Jiaotong-Liverpool University, China  \nREVIEWED BY  \nPia Giovannelli,  \nUniversity of Campania Luigi Vanvitelli, Italy  \nZhao Tingxiao,  \nZhejiang Provincial People’s Hospital, China  \n*CORRESPONDENCE  \nWeibo Hong  \n [hongweibo14@gmail.com](hongweibo14@gmail.com)  \nRECEIVED 06 February 2026  \nREVISED 31 March 2026  \nACCEPTED 08 April 2026  \nPUBLISHED 22 April 2026  \nCITATION  \nHong W (2026) Role of cancerassociated ﬁbroblast-derived exosomesin pancreatic cancer: clinical therapeutic potential and targeting challenges.  \nFront. Immunol. 17:1805988 .  \ndoi: 10.3389/fimmu.2026.1805988  \nCOPYRIGHT  \n© 2026 Hong. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRole of cancer-associated ﬁbroblast-derived exosomes in pancreatic cancer: clinical therapeutic potential and targeting challenges  \nWeibo Hong*  \nThe Third Afﬁliated Hospital, Southern Medical University, Guangzhou, Guangdong, China  \nPancreatic cancer (PC)’s lethality is determined by late diagnosis and treatment resistance. The tumor microenvironment (TME), driven by cancer-associated ﬁbroblasts (CAFs), is a crucial contributor. Within the TME, multiple cell types, including cancer cells, stromal cells, and immune cells, produce exosomes (EXOs), which are nanoscale extracellular vesicles (EVs) that mediate intercellular communication. Among these, CAF-derived EXOs (CAF-EXOs) conduct crucial interactions with cancer cells, conveying molecular cargo that promotes tumor proliferation, invasion, metastasis, metabolic reprogramming, and chemoresistance. Because CAF-EXOs provide a source of sensitive bloodbased biomarkers for early detection and represent potential therapeutic targets whose disruption might overcome stromal-driven resistance, research on CAFEXOs is crucial for addressing the fundamental shortcomings of current PC therapy. This narrative review synthesizes the critical signiﬁcance of CAF-EXOsas master regulators of PC development and therapeutic resistance. We reveal how these EVs convey specialized molecular cargo, including proteins, lipids, and non-coding RNAs. By identifying CAF-EXOs as essential mediators of chemoresistance and stromal immunosuppression, we emphasize their dual potential as attractive liquid biopsy biomarkers and therapeutic targets. The study concludes with a critical examination of the translational landscape, reviewing new strategies to target exosomal biogenesis, uptake, or cargo, while also noting the enormous biological and technological challenges that must be overcome to achieve therapeutic relevance. Ultimately, altering the CAF-EXO communication axis provides a new avenue to overcome stromal-driven resistance and improve outcomes in PC.  \nKEYWORDS  \nbiomarkers, cancer-associated ﬁbroblast-derived exosomes, clinical implications, exosomes, pancreatic cancer, target delivery  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nHong 10.3389/fimmu.2026.1805988  \nGRAPHICAL ABSTRACT  \n1 Introductions  \nPC is a highly fatal tumor, where early identiﬁcation dramatically increases survival. However, most patients are discovered atan advanced stage owing to a lack of early symptoms, leaving fewer than 20% eligible for curative surgery and resulting in a poor 5-year survival rate of just 13% (1–3) . Current diagnostic approaches, which combine imaging (computed tomography/magnetic resonance imaging) and invasive tissue biopsy (endoscopic ultrasoundguided ﬁne-needle aspiration/biopsy), lack sufﬁcient sensitivity fo","cbCaitF7ZlJVi4cm","https://ap.wps.com/l/cbCaitF7ZlJVi4cm","pdf",3668547,24,"English","# 1 Introductions\n## Early identification and diagnostic limitations\n## Surgical and systemic treatment challenges in PDAC\n## Tumor microenvironment and CAF roles in progression","[{\"question\":\"Why does pancreatic cancer often have poor outcomes?\",\"answer\":\"Most patients are diagnosed at advanced stages due to limited early symptoms, and treatment resistance leads to low long-term survival.\"},{\"question\":\"What role do CAF-derived exosomes play in pancreatic cancer?\",\"answer\":\"CAF-derived exosomes transmit molecular cargo that promotes tumor proliferation, invasion, metastasis, metabolic reprogramming, and chemoresistance.\"},{\"question\":\"How could CAF-EXOs be used clinically?\",\"answer\":\"They can serve as liquid biopsy biomarkers for early detection and as therapeutic targets to disrupt stromal-driven resistance.\"}]","Role of cancer-associated fibroblast-derived exosomes in pancreatic cancer: clinical therapeutic potential and targeting challenges | PDF",1790109047,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb1ce541601f9d25596f68fa44453919.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6d019a2d04f34b67c32fb9232392371.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e9eee8eb6bbc27bf308131f59a988c0.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44f0e0b618949122ffb4d0ec1fa8fd89.webp",980,1385]